JIM 2026; 3 (3): e1211
DOI: 10.61012/JIM_202608_1211

How reliable are large language models in metabolic dietetics? a cross-sectional benchmarking evaluation

JIM 2026; 3 (3): e1207
DOI: 10.61012/JIM_202608_1207

Enzyme replacement therapy for lysosomal storage diseases: learning from the past to shape the future

JIM 2026; 3 (3): e1209
DOI: 10.61012/JIM_202608_1209

Communication challenges in newborn screening: what the public knows (and doesn’t)

JIM 2026; 3 (3): e1215
DOI: 10.61012/JIM_202608_1215

Mind the bias: mapping and mitigating cognitive errors across the expanded newborn screening pathway

JIM 2026; 3 (2): e1169
DOI: 10.61012/JIM_202605_1169

Newborn screening for hypergalactosemia: a 42-year single-center experience in Italy

JIM 2026; 3 (2): e1171
DOI: 10.61012/JIM_202605_1171

External quality assurance in newborn screening: design, implementation, and outcomes of the SIMMESN program

JIM 2026; 3 (2): e1174
DOI: 10.61012/JIM_202605_1174

Effects of a relaxed diet on branched-chain amino acids trends in a patient with classic maple syrup urine disease

JIM 2026; 3 (1): e1119
DOI: 10.61012_20262_1119

Medical management and long-term outcome in classical ethylmalonic encephalopathy: insights from a prolonged follow-up

JIM 2026; 3 (1): e1121
DOI: 10.61012_20262_1121

From red flags to diagnosis: a hepatologist’s guide to Gaucher disease and acid sphingomyelinase deficiency in adults – insights from the Italian “Closer to Care” initiative

JIM 2026; 3 (1): e1123
DOI: 10.61012_20262_1123

Bone complications in Gaucher disease: a narrative review

JIM 2026; 3 (1): e1125
DOI: 10.61012/JIM_202602_1125

Unveiling gut microbiota signatures linked to the ketogenic dietary therapy